--- title: "Kengic: Net loss of 58.6268 million yuan in 2024" type: "News" locale: "en" url: "https://longbridge.com/en/news/237594559.md" description: "Kengic announced that the operating revenue for 2024 is expected to be 1.394 billion yuan, a year-on-year increase of 21.35%. The net loss attributable to shareholders of the listed company is expected to be 58.6268 million yuan, compared to a net loss of 77.9291 million yuan in the same period last year. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital stock from the capital reserve in 2024" datetime: "2025-04-25T14:30:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/237594559.md) - [en](https://longbridge.com/en/news/237594559.md) - [zh-HK](https://longbridge.com/zh-HK/news/237594559.md) generator: "portal-rs" --- # Kengic: Net loss of 58.6268 million yuan in 2024 Kengic announced that the operating revenue for 2024 is expected to be 1.394 billion yuan, a year-on-year increase of 21.35%. The net loss attributable to shareholders of the listed company is 58.6268 million yuan, compared to a net loss of 77.9291 million yuan in the same period last year. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital stock from capital reserves in 2024 ### Related Stocks - [688455.CN](https://longbridge.com/en/quote/688455.CN.md) ## Related News & Research - [Bollywood stars told to stop appearing in surrogate ads in Indian state's food safety drive](https://longbridge.com/en/news/296102317.md) - [Sinotrans schedules online briefing on 2026 interim results](https://longbridge.com/en/news/296213993.md) - [Tvardi Therapeutics: TTI-109 targets STAT3 to address unmet needs in UC with selective immune modulation and safety](https://longbridge.com/en/news/296374826.md) - [08:39 ETIntersignal Demonstrates Cross-Model Semantic State Transfer Between Local AI Systems](https://longbridge.com/en/news/296107862.md) - [DAZN completes acquisition of ViewLift](https://longbridge.com/en/news/296270796.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**